Bio-Techne (TECH) News Today $68.72 +2.35 (+3.54%) (As of 11/20/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Thrivent Financial for Lutherans Lowers Stock Position in Bio-Techne Co. (NASDAQ:TECH)Thrivent Financial for Lutherans trimmed its position in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 59.4% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 171,348 shares of the biotechnology compaNovember 21 at 3:59 AM | marketbeat.comBio-Techne Co. (NASDAQ:TECH) Shares Acquired by Natixis Advisors LLCNatixis Advisors LLC boosted its holdings in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 11.5% during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 158,056 shares of the biotechnology company's stock after purchasiNovember 21 at 3:52 AM | marketbeat.comBIO-TECHNE ANNOUNCES NEW DISTRIBUTION AGREEMENT WITH LEADER LIFE SCIENCESNovember 20 at 7:00 AM | prnewswire.comSegall Bryant & Hamill LLC Has $38.20 Million Stock Holdings in Bio-Techne Co. (NASDAQ:TECH)Segall Bryant & Hamill LLC increased its position in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 17.7% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 477,880 shares of theNovember 20 at 6:48 AM | marketbeat.comBio-Techne, ALZpath announce strategic partnershipNovember 18 at 4:23 PM | markets.businessinsider.comBIO-TECHNE AND ALZpath ANNOUNCE STRATEGIC PARTNERSHIP TO ADVANCE NEURODEGENERATIVE DISEASE RESEARCHNovember 18 at 7:00 AM | prnewswire.comBroadcrest Asset Management LLC Has $15.99 Million Holdings in Bio-Techne Co. (NASDAQ:TECH)Broadcrest Asset Management LLC raised its stake in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 100.0% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 200,000 shares of the biotechnology company's stoNovember 17, 2024 | marketbeat.comRoyce & Associates LP Acquires 17,296 Shares of Bio-Techne Co. (NASDAQ:TECH)Royce & Associates LP lifted its stake in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 2.1% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 845,398 shares of the biotechnology company's stock after buying an addNovember 15, 2024 | marketbeat.comBIO-TECHNE TO HIGHLIGHT NOVEL SOLUTIONS FOR CANCER AND CARRIER SCREENING AT AMP 2024 ANNUAL MEETING & EXPONovember 14, 2024 | prnewswire.comBio-Techne (NASDAQ:TECH) Stock Rating Upgraded by StockNews.comNovember 14, 2024 | americanbankingnews.comGeneva Capital Management LLC Purchases 17,114 Shares of Bio-Techne Co. (NASDAQ:TECH)Geneva Capital Management LLC increased its position in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 1.6% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,104,310 shares of the biotechnology company's stoNovember 13, 2024 | marketbeat.comBio-Techne Co. (NASDAQ:TECH) Stock Holdings Decreased by Sumitomo Mitsui Trust Group Inc.Sumitomo Mitsui Trust Group Inc. lessened its position in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 1.7% in the 3rd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 1,686,362 shares of the biotechnology company's stock after selling 28,November 13, 2024 | marketbeat.comBio-Techne (NASDAQ:TECH) Upgraded at StockNews.comStockNews.com raised shares of Bio-Techne from a "hold" rating to a "buy" rating in a report on Tuesday.November 12, 2024 | marketbeat.comUPDATED: BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORSNovember 11, 2024 | prnewswire.comBio-Techne Corporation: Bio-Techne Releases First Quarter Fiscal 2025 ResultsNovember 11, 2024 | finanznachrichten.deBIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORSNovember 11, 2024 | prnewswire.comBio-Techne Co. (NASDAQ:TECH) is Montanaro Asset Management Ltd's 3rd Largest PositionMontanaro Asset Management Ltd boosted its holdings in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 6.0% during the 3rd quarter, according to its most recent disclosure with the SEC. The firm owned 323,000 shares of the biotechnology company's stock after buying an additional 18,200 shares duringNovember 10, 2024 | marketbeat.comBio-Techne Co. (NASDAQ:TECH) Shares Sold by Ownership Capital B.V.Ownership Capital B.V. lessened its stake in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 17.6% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 974,648 shares of the biotechnology company's stockNovember 10, 2024 | marketbeat.comBIO-TECHNE TO PRESENT AT INVESTOR CONFERENCESNovember 8, 2024 | prnewswire.comAsset Management One Co. Ltd. Has $9.69 Million Stock Position in Bio-Techne Co. (NASDAQ:TECH)Asset Management One Co. Ltd. lowered its stake in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 7.8% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 121,637 shares of the biotechnology company's stock afterNovember 8, 2024 | marketbeat.comScaleReady Announces multiple G-Rex® Grants have been awarded to leading investigators at the Baylor College of Medicine's Center for Cell and Gene TherapyNovember 7, 2024 | prnewswire.comVan ECK Associates Corp Has $9.75 Million Stock Position in Bio-Techne Co. (NASDAQ:TECH)Van ECK Associates Corp cut its holdings in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 14.2% during the 3rd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 121,983 shares of the biotechnology company's stock afterNovember 7, 2024 | marketbeat.comBio-Techne Grants CFO Restricted Stock UnitsNovember 7, 2024 | markets.businessinsider.comBIO-TECHNE TO PRESENT AT THE SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) 39TH ANNUAL MEETINGNovember 6, 2024 | prnewswire.comStifel Nicolaus Reaffirms Their Hold Rating on Bio-Techne (TECH)November 5, 2024 | markets.businessinsider.comLUNAPHORE COMET™ PLATFORM PAVES THE WAY FOR SPATIAL BIOLOGY ADOPTION IN CLINICAL RESEARCHNovember 5, 2024 | prnewswire.comBio-Techne Co. (NASDAQ:TECH) Receives Consensus Recommendation of "Moderate Buy" from AnalystsShares of Bio-Techne Co. (NASDAQ:TECH - Get Free Report) have been given a consensus recommendation of "Moderate Buy" by the nine brokerages that are covering the firm, Marketbeat reports. Three equities research analysts have rated the stock with a hold rating and six have issued a buy rating onNovember 5, 2024 | marketbeat.comNew York State Common Retirement Fund Reduces Holdings in Bio-Techne Co. (NASDAQ:TECH)New York State Common Retirement Fund trimmed its holdings in shares of Bio-Techne Co. (NASDAQ:TECH - Free Report) by 22.0% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 521,913 shares of the biotechnology company's stock after seNovember 3, 2024 | marketbeat.comBio-Techne Reports First Quarter Fiscal 2025 ResultsNovember 2, 2024 | markets.businessinsider.comBio-Techne (NASDAQ:TECH) Upgraded to Buy at StockNews.comStockNews.com raised shares of Bio-Techne from a "hold" rating to a "buy" rating in a research note on Friday.November 1, 2024 | marketbeat.comAssenagon Asset Management S.A. Sells 13,954 Shares of Bio-Techne Co. (NASDAQ:TECH)Assenagon Asset Management S.A. trimmed its position in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 33.9% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 27,260 shares of the biotechnology company'sNovember 1, 2024 | marketbeat.comBio-Techne Corporation (TECH) Q1 2025 Earnings Call TranscriptOctober 31, 2024 | seekingalpha.comBio-Techne Corp (TECH) Q1 2025 Earnings Call Highlights: Navigating Growth and Challenges in a ...October 31, 2024 | finance.yahoo.comBio-Techne price target raised to $88 from $83 at ScotiabankOctober 31, 2024 | markets.businessinsider.comBio-Techne (NASDAQ:TECH) Price Target Raised to $88.00Scotiabank raised their price objective on shares of Bio-Techne from $83.00 to $88.00 and gave the company a "sector outperform" rating in a research report on Thursday.October 31, 2024 | marketbeat.comBio-Techne Corp. Q1 Profit Decreases, But Beats EstimatesOctober 30, 2024 | markets.businessinsider.comBio-Techne Co. to Issue Quarterly Dividend of $0.08 (NASDAQ:TECH)Bio-Techne Co. (NASDAQ:TECH) announced a quarterly dividend on Wednesday, October 30th. Shareholders of record on Monday, November 11th will be given a dividend of 0.08 per share by the biotechnology company on Friday, November 22nd. This represents a $0.32 annualized dividend and a yield of 0.41%.October 30, 2024 | marketbeat.comBio-Techne (NASDAQ:TECH) Shares Gap Up After Dividend AnnouncementBio-Techne (NASDAQ:TECH) Shares Gap Up After Dividend AnnouncementOctober 30, 2024 | marketbeat.comBio-Techne beats quarterly profit estimates, driven by diagnostic unit growth; shares riseOctober 30, 2024 | reuters.comBIO-TECHNE RELEASES FIRST QUARTER FISCAL 2025 RESULTSOctober 30, 2024 | prnewswire.comBIO-TECHNE DECLARES DIVIDENDOctober 30, 2024 | prnewswire.comCreative Planning Has $1.48 Million Stake in Bio-Techne Co. (NASDAQ:TECH)Creative Planning lowered its holdings in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 45.5% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 18,513 shares of the biotechnology company's stock after selling 15,429October 30, 2024 | marketbeat.comScaleReady Announces a G-Rex® Grant has been awarded to Luminary TherapeuticsOctober 29, 2024 | prnewswire.comIFM Investors Pty Ltd Raises Stock Position in Bio-Techne Co. (NASDAQ:TECH)IFM Investors Pty Ltd increased its stake in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 33.1% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 39,432 shares of the biotechnology company's stock after purchasing an additioOctober 28, 2024 | marketbeat.comBio-Techne (TECH) Gets a Hold from RBC CapitalOctober 26, 2024 | markets.businessinsider.comHahn Capital Management LLC Sells 21,302 Shares of Bio-Techne Co. (NASDAQ:TECH)Hahn Capital Management LLC lessened its position in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 32.3% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 44,709 shares of the biotechnology company's stock after selling 21,October 25, 2024 | marketbeat.comRaymond James & Associates Has $28.50 Million Stock Holdings in Bio-Techne Co. (NASDAQ:TECH)Raymond James & Associates raised its holdings in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 2.4% in the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 356,597 shares of the biotechnology company's stock after acquiring an additional 8,457 shares durOctober 24, 2024 | marketbeat.comBio-Techne (TECH) Set to Announce Quarterly Earnings on WednesdayBio-Techne (NASDAQ:TECH) will be releasing earnings before the market opens on Wednesday, October 30, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=634556)October 23, 2024 | marketbeat.comBio-Techne Co. (NASDAQ:TECH) Shares Sold by Allspring Global Investments Holdings LLCAllspring Global Investments Holdings LLC decreased its holdings in Bio-Techne Co. (NASDAQ:TECH - Free Report) by 38.4% in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 656,711 shares of the biotechnology company's stock after selOctober 22, 2024 | marketbeat.comBio-Techne Gears Up for Q1 Earnings Release: What's in the Cards?October 21, 2024 | msn.com Get Bio-Techne News Delivered to You Automatically Sign up to receive the latest news and ratings for TECH and its competitors with MarketBeat's FREE daily newsletter. Email Address Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development… YES, I WANT THE #1 CRYPTO NOW TECH Media Mentions By Week TECH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TECH News Sentiment▼0.880.45▲Average Medical News Sentiment TECH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TECH Articles This Week▼87▲TECH Articles Average Week Get Bio-Techne News Delivered to You Automatically Sign up to receive the latest news and ratings for TECH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies A News Today MTD News Today ILMN News Today WAT News Today CRL News Today BIO News Today BRKR News Today PACB News Today HBIO News Today TMO News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TECH) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bio-Techne Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bio-Techne With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
